Articles
-
YAP/TAZ dull the STING of aging
Commentary|Published on: 5 Aug 2022 -
Promoting healthy cardiovascular aging: emerging topics
Review|Published on: 29 Jul 2022 -
SGLT2 inhibitors in patients with HFpEF: how old is too old?
Commentary|Published on: 20 Jul 2022 -
In-depth characterization of a mouse model of postoperative atrial fibrillation
Original Research Article|Published on: 19 Jul 2022 -
A role for somatic mutations in the evolution of lifespan
Commentary|Published on: 13 Jul 2022 -
Deficient Lmna in fibroblasts: an emerging role of non-cardiomyocytes in DCM
Editorial|Published on: 8 Jul 2022 -
Mutant SRF and YAP1 remodel the chromatin to entice cardiac myocyte nuclear division
Editorial|Published on: 7 Jul 2022 -
SRF and Yap1, partners in cardiac repair
Editorial|Published on: 5 Jul 2022 -
Gut microbiota in sarcopenia and heart failure
Review|Published on: 5 Jul 2022
See more
Most Downloaded Articles Published In
-
Epigenetic dysregulation in cardiovascular aging and disease
Review|Published on: 23 Aug 2021 -
Ser9 phosphorylation of GSK-3β promotes aging in the heart through suppression of autophagy
Original Research Article|Published on: 23 Aug 2021 -
Editors’ Preamble to The Journal of Cardiovascular Aging
Editorial|Published on: 27 Apr 2021 -
S-nitrosoglutathione reductase (GSNOR) deficiency accelerates cardiomyocyte differentiation of induced pluripotent stem cells
Original Research Article|Published on: 7 Sep 2021 -
Adenine base editing to treat progeria syndrome and extend the lifespan
Commentary|Published on: 17 Jun 2021
-
Mutant SRF and YAP synthetic modified mRNAs drive cardiomyocyte nuclear replication
Original Research Article|Published on: 19 May 2022 -
STEMIN and YAP5SA synthetic modified mRNAs regenerate and repair infarcted mouse hearts
Original Research Article|Published on: 15 Jun 2022 -
Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction
Original Research Article|Published on: 5 Jan 2022 -
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
Commentary|Published on: 1 Jan 2022 -
Effects of tamoxifen inducible MerCreMer on gene expression in cardiac myocytes in mice
Resource Report|Published on: 5 Jan 2022
See more
About The Journal
-
ISSN
2768-5993 (Online)
Publisher
OAE Publishing Inc.
Article Processing Charges
Free of charge before December 2024
Manuscript Processing Cycle (peer reviewed only)
Time from submission to first decision: 16 days (8-27 days)
Time from submission to publication: 30 days (14-45 days)
(not include the time that authors spend on revision)
-
Editor-in-Chief
Ali J. Marian
Publishing Model
Gold Open Access
Copyright
Copyright is retained by author(s)
-
Publication Frequency
Quarterly
Indexing
Open Archives
-
Portico
All published articles will be preserved here permanently:
https://www.portico.org/publishers/oae/